Bausch + Lomb Corporation

Day range

$17.30 – $17.76

Open

$17.41

Prev close

$17.47

Volume

306.8K

Market cap

$6.24B

Shares out

357.39M

P/E

—

P/S

1.17

P/B

0.98

P/FCF

45.55

ROE

-2.7%

ROA

-1.2%

Debt/Equity

0.80

Div yield

0.00%

As of Oct 23, 2026

• Ceo appointmentOct 13, 2026

  "Thomas J. Appio, who is currently Chairman of the Board, was appointed to serve as the interim Chief Executive Officer of the Company, effective as of October 12, 2026."

• Director departureAug 6, 2026

  The resignations of the Resigning Directors were not due to any disagreement or dispute with the Company. In connection with their resignation and entry into a general mutual release of certain claims, the Company has agreed to pay the Resigning Directors prorated cash compensation for their service and accelerated the vesting, in full, of the outstanding and unvested restricted stock unit awards received by the Resigning Directors as part of their 2026 annual grant.

• Annual meeting resultsMay 20, 2026

  At the Annual Meeting of Shareholders (the "Annual Meeting") of Bausch + Lomb Corporation (the "Company") held on Wednesday, May 20, 2026, the Company's shareholders voted on the following proposals... The results of each matter voted upon are as follows: Proposal: Election of Directors. The shareholders elected the following individuals to the Company's Board of Directors, to serve until the close of the Company's 2027 Annual Meeting of Shareholders.

• Credit facility drawJan 2, 2026

  The Fourth Amendment provides for a new $2,802,125,000 tranche of term loans maturing in 2031 (the 'Replacement Term Loans'), the proceeds of which were used to refinance all of the Company's outstanding term B loans due 2031 and term B loans due 2028.

• Director departureDec 17, 2025

  to fill the vacancies created by the departure of Brett Icahn and Gary Hu from the Board in August 2025.

Days to cover

9.8

Short interest

2.96M

Avg volume

300.65K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Veterinary Ophthalmology Equipment Market by Product, Animal Type, Application, End User, Region Report Forecasts Market to Reach USD 0.83 Billion by 2031, Growing at a 7.7% CAGR
  positiveGlobeNewswire Inc.· Sep 24, 2026
• BLCO Gains European CE Mark for Next-Gen SeeLyra Femtosecond Laser
  positiveZacks Investment Research· Sep 14, 2026
• Nicox Announces Extension of Cash Runway
  neutralGlobeNewswire Inc.· Sep 2, 2026
• Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others
  positiveGlobeNewswire Inc.· Jul 13, 2026
• A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story
  neutralThe Motley Fool· Mar 24, 2026